| Protective effects of the combination of α-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection O Cirioni, C Silvestri, R Ghiselli, F Orlando, A Riva, F Mocchegiani, ... Journal of antimicrobial chemotherapy 62 (6), 1332-1338, 2008 | 84 | 2008 |
| Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study Z Pasquini, I Barocci, L Brescini, B Candelaresi, S Castelletti, V Iencinella, ... International Journal of Infectious Diseases 111, 31-36, 2021 | 39 | 2021 |
| In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents F Barchiesi, C Silvestri, D Arzeni, G Ganzetti, S Castelletti, O Simonetti, ... Medical Mycology 47 (3), 321-326, 2009 | 36 | 2009 |
| Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy L Brescini, G Morroni, C Valeriani, S Castelletti, M Mingoia, S Simoni, ... BMC Infectious Diseases 19, 1-9, 2019 | 22 | 2019 |
| Economic consequences of investing in anti-HCV antiviral treatment from the Italian NHS perspective: a real-world-based analysis of PITER data A Marcellusi, R Viti, LA Kondili, S Rosato, S Vella, FS Mennini Pharmacoeconomics 37, 255-266, 2019 | 21 | 2019 |
| Spread of colistin resistance gene mcr-1 in Italy: characterization of the mcr-1.2 allelic variant in a colistin-resistant blood isolate of Escherichia coli S Simoni, G Morroni, A Brenciani, C Vincenzi, O Cirioni, S Castelletti, ... Diagnostic microbiology and infectious disease 91 (1), 66-68, 2018 | 21 | 2018 |
| In vitro activity of the lipopeptide derivative (Pal‐lys‐lys‐NH2), alone and in combination with antifungal agents, against clinical isolates of dermatophytes O Simonetti, D Arzeni, G Ganzetti, C Silvestri, O Cirioni, E Gabrielli, ... British Journal of Dermatology 161 (2), 249-252, 2009 | 20 | 2009 |
| Efficacy of the Combination of Tachyplesin III and Clarithromycin in Rat Models of Escherichia coli Sepsis O Cirioni, R Ghiselli, C Silvestri, W Kamysz, F Orlando, A Riva, E Kamysz, ... Antimicrobial agents and chemotherapy 52 (12), 4351-4355, 2008 | 18 | 2008 |
| Use of dalbavancin in skin, bone and joint infections: a real-life experience in an Italian center L Brescini, F Della Martera, G Morroni, S Mazzanti, M Di Pietrantonio, ... Antibiotics 10 (9), 1129, 2021 | 11 | 2021 |
| Ceftazidime–Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study M Di Pietrantonio, L Brescini, J Candi, M Gianluca, F Pallotta, S Mazzanti, ... Antibiotics 11 (3), 321, 2022 | 7 | 2022 |
| Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort MG Quaranta, L Ferrigno, X Tata, F D'Angelo, M Massari, C Coppola, ... Digestive and Liver Disease 53 (12), 1603-1609, 2021 | 3 | 2021 |
| Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy G Morroni, L Brescini, A Antonelli, V Di Pilato, S Castelletti, A Brenciani, ... Journal of global antimicrobial resistance 30, 377-383, 2022 | 2 | 2022 |
| Therapy with direct-acting antiviral agents in transplanted patients with HCV recurrence: A retrospective analysis S Castelletti, M Di Pietrantonio, G Morroni, A Fiorentini, M Tomasetti, ... Hepatitis Monthly 19 (7), 2019 | 1 | 2019 |
| Antiretroviral therapy management and rationalisation of available resources O Cirioni, S Castelletti, C Ucciferri, K Falasca, E Orsetti, S Mazzocato, ... Le infezioni in medicina 23 (4), 330-335, 2015 | 1 | 2015 |
| La resistenza agli antibiotici in Pseudomonas aeruginosa: studio molecolare ed epidemiologico in un nosocomio marchigiano S Castelletti Università Politecnica delle Marche, 2020 | | 2020 |
| L'Italia come modello per l'Europa e per il mondo nelle politiche sanitarie per il trattamento dell'epatite cronica da HCV LA Kondili, S Vella, MG Quaranta, S Rosato, ME Tosti, LE Weimer, ... NOTIZIARIO DELL'ISTITUTO SUPERIORE DI SANITÀ 31, 3-7, 2018 | | 2018 |
| P37 C Valeriani, A Costantini, A Giacometti, O Cirioni, B Canovari, M Balducci, ... Age (yers) 52, 26, 2017 | | 2017 |
| Efficacy and costs of Direct Acting Antivirals (DAAS) for the treatment of HCV Iinfection amnog HCV-monoinfected and HIV/HCV co-infected patients in real-life setting G Corinaldesi, R Sentinelli, S Guglielmi, V Barocci, S Castelletti, ... EJHP. EUROPEAN JOURNAL OF HOSPITAL PHARMACY 24, 26-26, 2017 | | 2017 |
| CP-159 Direct acting antivirals (DAAS) for the treatment of HCV infection in HIV/HCV coinfected patients: A clinical experience G Corinaldesi, R Sentinelli, S Guglielmi, E Orsetti, S Castelletti, ... European Journal of Hospital Pharmacy 23 (Suppl 1), A70-A71, 2016 | | 2016 |
| Mycocladus corymbifer (formerly Absidia corymbifera): report of two cases and review of primary cutaneous Mycocladus infections, 532 Alsoub H, see Almaslamani M Altas K, see … NE Babady, JE Bestrom, DJ Jespersen, MF Jones, EM Beito, ... Medical Mycology 48, e5-e19, 2010 | | 2010 |
